Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn

Gersony, 1984, Neonatal pulmonary hypertension: pathophysiology, classification and etiology, Clin Perinatol, 11, 517, 10.1016/S0095-5108(18)30899-6

Drummond, 1977, The clinical profile of the newborn with persistent pulmonary hypertension, Clin Pediatr, 16, 335, 10.1177/000992287701600407

Levin, 1976, Persistent pulmonary hypertension of the newborn infant, J Pediatr, 89, 626, 10.1016/S0022-3476(76)80405-2

Kinsella, 1995, Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn, J Pediatr, 126, 853, 10.1016/S0022-3476(95)70197-4

Short, 1987, Extracorporeal membrane oxygenation in the management of respiratory failure in the newborn, Clin Perinatol, 14, 737, 10.1016/S0095-5108(18)30760-7

Roberts, 1992, Inhaled nitric oxide in persistent pulmonary hypertension of the newborn, Lancet, 340, 818, 10.1016/0140-6736(92)92686-A

Kinsella, 1992, Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn, Lancet, 340, 819, 10.1016/0140-6736(92)92687-B

Kinsella, 1993, Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide, J Pediatr, 123, 103, 10.1016/S0022-3476(05)81551-3

Finer, 1994, Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response, J Pediatr, 124, 302, 10.1016/S0022-3476(94)70324-8

Clark, 1994, High-frequency ventilation, J Pediatr, 124, 661, 10.1016/S0022-3476(05)81352-6

Meredith, 1989, Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons, J Appl Physiol, 66, 2150, 10.1152/jappl.1989.66.5.2150

Kinsella, 1991, HFOV vs IMV: early hemodynamic effects in the premature baboon with HMD, Pediatr Res, 29, 160, 10.1203/00006450-199102000-00012

Froese, 1989, A comparison of ventilation strategies for the use of high-frequency oscillatory ventilation in the treatment of hyaline membrane disease, Acta Anaesthesiol Scand, 33, 102, 10.1111/j.1399-6576.1989.tb03013.x

Clark, 1994, Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation, J Pediatr, 124, 447, 10.1016/S0022-3476(94)70374-4

Varnholt, 1992, High- frequency oscillatory ventilation and extracorporeal membrane oxygenation in severe persistent pulmonary hypertension of the newborn, Eur J Pediatr, 151, 769, 10.1007/BF01959088

Kinsella, 1994, Efficacy of inhalational nitric oxide therapy in the clinical management of persistent pulmonary hypertension of the newborn, Chest, 105, 92S, 10.1378/chest.105.3_Supplement.92S

Kinsella, 1992, Cardiac performance in ECMO candidates: echocardiographic predictors for ECMO, J Pediatr Surg, 27, 44, 10.1016/0022-3468(92)90102-D

Kinsella, 1993, Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn, Pediatrics, 91, 997, 10.1542/peds.91.5.997

Stolar, 1991, Extracorporeal membrane oxygenation and neonatal respiratory failure: experience from the extracorporeal life support organization, J Pediatr Surg, 26, 563, 10.1016/0022-3468(91)90708-2

Schwendeman, 1992, Frequency of chronic lung disease in infants with severe respiratory failure treated with high-frequency oscillatory ventilation and/or extracorporeal membrane oxygenation, Crit Care Med, 20, 372, 10.1097/00003246-199203000-00014

Abman, 1995, Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: the physiology matters!, Pediatrics, 96, 1153, 10.1542/peds.96.6.1153

Fanaroff, 1992, Center variability: an inherent component of multicenter clinical trials—advantage or disadvantage [abstract]?, Pediatr Res, 31, 246A